RLFINE
APLICATIONS
New Drug Approval | FDA Approves Colchicine (Lodoco) as First Anti-Inflammatory...
U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease
LODOCO® (colchicine, 0.5 mg tablets) Reduces Cardiac Event Risk in Adult Patients with Established Atherosclerotic Cardiovascular...
